Thawornchai LimjindapornJutatip PanaamponShilu MalakarSansanee NoisakranPa thai YenchitsomanusMahidol UniversityThailand National Center for Genetic Engineering and Biotechnology2018-12-212019-03-142018-12-212019-03-142017-01-29Biochemical and Biophysical Research Communications. Vol.483, No.1 (2017), 58-63109021040006291X2-s2.0-85009266728https://repository.li.mahidol.ac.th/handle/20.500.14594/41973© 2017 Elsevier Inc. Dengue virus is the causative agent of dengue fever, dengue hemorrhagic fever, and dengue shock syndrome. High rates of dengue virus replication and virion production are related to disease severity. To identify anti-DENV compounds, we performed cell-based ELISA testing to detect the level of DENV E protein expression. Among a total of 83 inhibitors, eight were identified as inhibitors with antiviral activity. Epidermal growth factor receptor inhibitor II (EGFR/ErbB-2/ErbB-4 inhibitor II) and protein tyrosine phosphatase inhibitor IV (PTP inhibitor IV) significantly inhibited dengue virus production and demonstrated low toxicity in hepatocyte cell lines. Our results suggest the efficacy of tyrosine kinase/phosphatase inhibitors in decreasing dengue virus production in HepG2 cells.Mahidol UniversityBiochemistry, Genetics and Molecular BiologyArticleSCOPUS10.1016/j.bbrc.2017.01.006